Cancer Mortality Associated with Cigarette Consumption in the Colombian Caribbean 2009-2013
DOI:
https://doi.org/10.17533/udea.rfnsp.v37n2a13Keywords:
mortality, cancer, tobacco use, potential years of life lostAbstract
Objective: To estimate the mortality attributable to cigarette consumption in the Colombian Caribbean during the years 2009-2013. Methodology: retrospective descriptive ecological study. The number of deaths was obtained from the National Administrative Department of Statistics. The proportion and deaths attributable to smoking were estimated from the population etiological fraction, using a method dependent on prevalence of consumption. Potential years of life lost (3% discount) were calculated. The information was analyzed in Excel and Epitat 4.1 programs. Results: There were 964 deaths (method i), 1375 deaths (method ii) and 94 deaths (method iii). Cancer of the trachea, lungs and bronchi was the neoplasia that most contributed to this mortality. A total of 17715 potential years of life were lost (7745 in men, 9970 in women). Conclusion: Tobacco use contributes significantly to cancer mortality and increases in potential years of life lost.
Downloads
References
(1). Kong KA, Jung-Choi K-H, Lim D, Lee HA, Lee WK, Baik SJ, et al. Comparison of prevalence- and smoking impact ratio-based methods of estimating smoking-attributable fractions of deaths. J. Epidemiol. 2016;26(3):145-54. DOI: http://dx.doi.org/10.2188/jea.JE20150058.
(2). Sánchez C, San Martín V. Mortalidad atribuible al tabaquismo durante los años 2001-2007 en Paraguay. Rev Parag Epidemiol. 2010:1(1):27-3l.
(3). Varona Pérez P, Herrera Travieso D, García Roche RG, et al. Mortalidad atribuible al tabaquismo en Cuba. Rev. Cuba. Salud Pública. 2009; 35(2):1-13.
(4). Drope J, Schluger N, Cahn Z, et al. The Tobacco Atlas. 6.ª ed. Atlanta: American Cancer Society and Vital Strategies; 2018.
(5). Gutiérrez-Abejón E, Rejas-Gutiérrez J, Criado-Espegel P, et al. Impacto del consumo de tabaco sobre la mortalidad en España en el año 2012. Med. Clin. [internet]. 2015 [citado 2019 ene. 21];145(12):520-5. Disponible en: https://www.sciencedirect.com/science/article/pii/S002577531500250X. DOI: https://doi.org/10.1016/j.medcli.2015.03.013.
(6). Oliveira AF, Valente IG, Leite IC. Aspecto da mortalidade atribuível ao tabaco: Revisão sistemática. Revista de Saude Publica. 2008;42(2):335-45. DOI: http://dx.doi.org/10.1590/S0034-89102008005000001.
(7). Gobierno Nacional de la República de Colombia, Ministerio de Justicia y del Derecho, Observatorio de Drogas de Colombia, Ministerio de Salud y Protección Social, Oficina de las Naciones Unidas contra la Droga y el Delito (UNODC). Comisión Interamericana para el Control del Abuso de Drogas (CICAD) de la Organización de los Estados Americanos (OEA) y Embajada de los Estados Unidos en Colombia (INL). Estudio nacional sobre el consumo de sustancias psicoactivas en Colombia 2013. Bogotá; 2014.
(8). Pardo C, Piñeros M. Consumo de tabaco en cinco ciudades de Colombia. Encuesta Mundial de Tabaquismo en Jóvenes, 2007. Biomédica. 2010;30(4):509-18. DOI: https://doi.org/10.7705/biomedica.v30i4.289.
(9). Pérez-Ríos M, Santiago-Pérez MI, Caramés SC, et al. Mortalidad y años de esperanza de vida perdidos a causa del tabaquismo en personas mayores de 35 años en Galicia en el período 2001-2006. Rev. Esp. Salud Pública. 2009;83(4):557-65.
(10). Alexandrov LB, Ju YS, Haase K, et al. Mutational signatures associated with tobacco smoking in human cancer. Science. 2016;354(6312):618-22. DOI: http://dx.doi.org/10.1126/science.aag0299.
(11). Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality -- Beyond established causes. N. Engl. J. Med. 2015;372(7):631-40. DOI: http://dx.doi.org/10.1056/NEJMsa1407211.
(12). Cogollo Milanés Z, Gómez E. Consumo de cigarrillo entre estudiantes de Cartagena, Colombia: factores familiares asociados. Rev. Fac. Nac. Salud Pública. 2009;27(3):259-63.
(13). Archivo Nacional de Datos (ANDA). Microdatos. Estadísticas vitales [internet]. Colombia: ANDA. [citado 2016 feb. 21]. Disponible en: http://microdatos.dane.gov.co/index.php/catalog/MICRODATOS/about_collection/22/5
(14). Organización Panamericana de la Salud, Oficina Sanitaria Panamericana, Oficina Regional de la Organización Mundial de la Salud. Clasificación Estadística Internacional de Enfermedades y Problemas Relacionados con la Salud. Decima revisión. CIE 10. Volumen 1. Publicación Científica No. 554 [internet] 1985 [citado 2019 abr. 9]. Disponible en: http://ais.paho.org/classifications/Chapters/pdf/Volume1.pdf.
(15). Banegas JR, Díez-Gañán L, Bañuelos-Marco B, et al. Mortalidad atribuible al consumo de tabaco en España en 2006. Med. Clin. 2011;136(3):91-138. DOI: http://dx.doi.org/10.1016/j.medcli.2010.03.039.
(16). Pérez-Ríos M, Montes A. Methodologies used to estimate tobacco-attributable mortality: A review. BMC Public Health. 2008;8:22. DOI: http://dx.doi.org/10.1186/1471-2458-8-22.
(17). Profamilia. Encuesta Nacional de Demografía y Salud 2010. Encuesta Nacional de Demografía y Salud; 2010.
(18). U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smokingand Health; 2014.
(19). Ginsberg GM, Geva H. The burden of smoking in Israel-attributable mortality and costs (2014). Isr. J. Health Policy Res. 2014;3(28):1-9. DOI: http://dx.doi.org/10.1186/2045-4015-3-28.
(20). Tachfouti N, Raherison C, Najdi A, et al. Smoking-attributable mortality in Morocco: Results of a prevalence-based study in Casablanca. Arch. Public. Heal. 2014;72(23):1-8. DOI: http://dx.doi.org/10.1186/2049-3258-72-23.
(21). Odongua N, Chae YM, Kim MR, Yun JE, et al. Associations between smoking, screening, and death caused by cervical cancer in Korean women. Yonsei Med. J. 2007;48(2):192-200. DOI: http://dx.doi.org/10.3349/ymj.2007.48.2.192.
(22). Rohrmann S, Genkinger JM, Burke A, et al. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology. 2007;69(4):721-5. DOI: http://dx.doi.org/10.1016/j.urology.2006.12.020.
(23). Braithwaite D, Izano M, Moore DH, et al. Smoking and survival after breast cancer diagnosis: A prospective observational study and systematic review. Breast Cancer Res. Treat. 2012;136(2):521-33. DOI: http://dx.doi.org/10.1007/s10549-012-2276-1.
(24). Jiang JM, Zeng XJ, Chen JS, et al. Smoking and mortality from esophageal cancer in China: A large case-control study of 19,734 male esophageal cancer deaths and 104,846 living spouse controls. Int. J. Cancer. 2006;119(6):1427-32. DOI: http://dx.doi.org/10.1002/IJC.21887.
(25). Castaño E, Parra H. Dejar de fumar: factor protector de cáncer gástrico. Rev. Hacia la Promoción de la Salud. 2007;12:125-32.
(26). Erazo MB, Amigo HC, Oyarzún MG, et al. Tabaquismo activo y cancer pulmonar: determinación de fracciones atribuibles por sexo. Rev. Méd. Chil. 2008;136(10):1272-80. DOI: http://dx.doi.org/10.4067/S0034-98872008001000006.
(27). Weinmann S, Shapiro JA, Rybicki BA, et al. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control. 2010;21(1):117-25. DOI: http://dx.doi.org/10.1007/s10552-009-9441-9.
(28). Román MD, Niclis C, Tumas N, et al. Tobacco smoking patterns and differential food effects on prostate and breast cancers among smokers and nonsmokers in Córdoba, Argentina. Eur J Cancer Prev. 2014;23(4):310-8. DOI: http://dx.doi.org/10.1097/CEJ.0000000000000044.
(29). Zheng W, McLerran DF, Rolland BA, et al. Burden of total and cause-specific mortality related to tobacco smoking among adults aged ≥ 45 years in Asia: A pooled analysis of 21 cohorts. PLoS Med. 2014;11(4):e1001631. DOI: http://dx.doi.org/10.1371/journal.pmed.1001631.
(30). Singh S, Pillai S, Chellappan S. Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol. 2011;2011:456743. DOI: http://dx.doi.org/10.1155/2011/456743.
(31). Davis VN, Lavender A, Bayakly R, et al. Using current smoking prevalence to project lung cancer morbidity and mortality in Georgia by 2020. Prev. Chronic. Dis. 2013;10:E74. DOI: http://dx.doi.org/10.5888/pcd10.120271.
(32). Malhotra J, Malvezzi M, Negri E, et al. Risk factors for lung cancer worldwide. Eur. Respir. J. 2016;48(3):889-902. DOI: http://dx.doi.org/10.1183/13993003.00359-2016.
(33). Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017 ;67(1):7-30. DOI: http://dx.doi.org/10.3322/caac.21387.
(34). Bae JM, Li ZM, Shin MH, et al. Lung cancer incidence by smoking status in korean men: 16-years of observations in the Seoul Male Cancer Cohort Study. J Korean Med Sci. 2013;28(4):636-7. DOI: http://dx.doi.org/10.3346/jkms.2013.28.4.636.
(35). Roura E, Castellsagué X, Pawlita M, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort. Int. J. Cancer. 2014;135(2):453-66. DOI: http://dx.doi.org/10.1002/ijc.28666.
(36). Huncharek M, Sue Haddock K, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: A meta-analysis of 24 prospective cohort studies. Am. J. Public Health. 2010;100(4):693-701. DOI: http://dx.doi.org/10.2105/AJPH.2008.150508.
(37). República de Colombia. Ministerio de Salud y Protección Social. Instituto Nacional de Cancerología. Empresa Social del Estado. El cáncer de mama: un problema creciente en Colombia. Hechos & Acciones. 2012;4(2):1-12.
(38). Piñeros M, Pardo C, Gamboa O, et al. Atlas de mortalidad por cáncer en Colombia. Bogotá: Ministerio de la Protección Social, Instituto Nacional de Cancerología, ESE; 2010.
(39). Bravo L, Muñoz N. Epidemiology of cancer in Colombia. Colomb. Med. 2018;49(1):9-12. DOI: http://dx.doi.org/10.25100/cm.v49i1.3877.
(40). Pinto MT, Pichon-Riviere A, Bardach A. The burden of smoking-related diseases in Brazil: Mortality, morbidity and costs estimativa. Cad. Saude Publica. 2015;31(6):1283-97. DOI: http://dx.doi.org/10.1590/0102-311X00192013.
Downloads
Published
How to Cite
Issue
Section
License
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
